Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05455905 · ClinicalTrials.gov registry record
Voice Biomarkers Predictive of Depression and Anxiety
A clinical trial, sponsored by Kintsugi Mindful Wellness.
- Completed
- Registry status
- 19,533
- Enrollment target
NCT05455905: Completed study, sponsored by Kintsugi Mindful Wellness.
NCT05455905 is a clinical trial that has completed, run by Kintsugi Mindful Wellness. The registered enrollment target is 19,533 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05455905 has completed, sponsored by Kintsugi Mindful Wellness.
- COMPLETED
- Registry status
- 19,533 participants
- Enrollment target
Study Summary
The objective of this study is to collect data to improve the sensitivity and specificity of Kintsugi Voice's (formerly KiVATM) predictions on audio files. A web-based audio recording tool will be used to record voice sample and ask participants the PHQ-9 and GAD-7 questions. A voluntary subset of participants will then be assessed by mental health professionals with the Hamilton Depression Rating Scale (HAM-D) and Hamilton Anxiety Rating Scale (HAM-A) scores.
Primary Outcome
Participants will be interviewed by mental health professionals using the clinically validated Hamilton Depression Rating Scale, which has a score range of 0 to 54, where higher scores are associated with higher severity of depression.
Interventions
- DIAGNOSTIC_TEST Patient Health Questionnaire-9
- DIAGNOSTIC_TEST Generalized Anxiety Disorder-7
- DIAGNOSTIC_TEST Hamilton Depression Rating Scale
- DIAGNOSTIC_TEST Hamilton Anxiety Rating Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19,533 participants |
| Start Date | 2021-09-14 |
| Est. Completion | 2022-09-11 |
What the finished NCT05455905 record still lists
NCT05455905 is an observational study that tracks outcomes without assigning an intervention. Its 19,533 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 4 interventions - of which Patient Health Questionnaire-9 is the first listed.
NCT05455905 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05455905 about?
NCT05455905 is a clinical study titled "Voice Biomarkers Predictive of Depression and Anxiety". The objective of this study is to collect data to improve the sensitivity and specificity of Kintsugi Voice's (formerly KiVATM) predictions on audio files. A web-based audio recording tool will be used to record voice sample and ask participants the PHQ-9 and GAD-7 questions. A voluntary subset of p...
What is the current status of trial NCT05455905?
This trial is currently completed. The enrollment target is 19,533 participants. The study started on 2021-09-14. Estimated completion is 2022-09-11.
What interventions are being tested in trial NCT05455905?
The interventions under investigation include: Patient Health Questionnaire-9 (DIAGNOSTIC_TEST), Generalized Anxiety Disorder-7 (DIAGNOSTIC_TEST), Hamilton Depression Rating Scale (DIAGNOSTIC_TEST), Hamilton Anxiety Rating Scale (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05455905?
This trial is sponsored by Kintsugi Mindful Wellness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07152249 · 19,480 participants · NA
Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial
- NCT05555095 · 19,331 participants
Examining Digital Health Care Delivery Models Through Medicaid Collaborative
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI